Dr. Kwong is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10175 Fortune Pkwy
Suite 1203
Jacksonville, FL 32256Phone+1 904-519-5292Fax+1 904-519-5296
Education & Training
University of AlbertaClass of 1990
Certifications & Licensure
FL State Medical License 2001 - 2026
PA State Medical License 1997 - 2002- American Board of Dermatology Dermatology
- American Board of Dermatology Pediatric Dermatology
Awards, Honors, & Recognition
- Top MD Consumers Checkbook
- Fellow (FAAD) American Academy of Dermatology
Clinical Trials
- Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis Start of enrollment: 2017 Mar 28
Publications & Presentations
PubMed
- 12 citationsSafety and Efficacy of VP-102, a Proprietary, Drug-Device Combination Product Containing Cantharidin, 0.7% (w/v), in Children and Adults With Molluscum Contagiosum: Tw...Lawrence F. Eichenfield, Wendy McFalda, Bradford Brabec, Elaine C. Siegfried, Pearl C Kwong
JAMA Dermatology. 2020-12-01 - 6 citationsPooled Results of Two Randomized Phase III Trials Evaluating VP-102, a Drug-Device Combination Product Containing Cantharidin 0.7% (w/v) for the Treatment of Molluscum...Lawrence F. Eichenfield, Elaine C. Siegfried, Pearl Kwong, Mark McBride, Jayson M. Rieger
American Journal of Clinical Dermatology. 2021-02-18 - 3 citationsTapinarof cream 1% once daily: Significant efficacy in the treatment of moderate to severe atopic dermatitis in adults and children down to 2 years of age in the pivot...Jonathan I Silverberg, Lawrence F Eichenfield, Adelaide A Hebert, Eric L Simpson, Linda Stein Gold
Journal of the American Academy of Dermatology. 2024-09-01
Journal Articles
- Safety and Efficacy of VP-102, a Proprietary, Drug-Device Combination Product Containing Cantharidin, 0.7% (w/v), in Children and Adults with Molluscum ContagiosumLawrence F Eichenfield, Wendy Mcfalda, Pearl Kwong, JAMA Dermatology
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
